European Blood Pressure Intensive Control After Stroke

Stroke is the third most common cause of death worldwide and the leading cause of disability. High blood pressure is an important risk factor for stroke. Lowering a person's blood pressure reduces the risk of future stroke or heart attack, and current guidelines recommend treatment to a target of \<130mmHg for secondary prevention. Home blood pressure measurement and telemonitoring are acceptable to patients, but there is uncertainty over the use of out of office blood pressure measurements in stroke patients in guidelines. This is a study designed to establish the feasibility of a larger clinical trial, comparing home blood pressure monitoring, telemonitoring and medication titration with standard care. The study hypothesis is that home BP measurement and telemonitoring with medication titration may lead to improved BP control compared to standard of care clinical practice.

NCT Number	NCT04647292
Lead Sponsor	University College Dublin Collaborators: St Vincent's University Hospital, Ireland, Cork University Hospital, Tallaght University Hospital, HRB Stroke Trials Network Ireland, National University of Ireland, Galway, Ireland, Mater Misericordiae University Hospital, St. James's Hospital, Ireland, Connolly Hospital Blanchardstown
Conditions	Ischemic Stroke, Transient Ischemic Attack
Enrollment	142 participants
Start Date	2024-05-02
Primary Completion	2025-12 (estimated)
Study Completion	2026-03 (estimated)
Updated on ClinicalTrials.gov	2024-07-11